Digital Finance: Amending Directive regarding Digital Operational Resilience requirementsNov 10, 2022
Conclusion of an agreement under GATS on the modification of schedules of specific commitmentsNov 10, 2022
Growing hate crimes against LGBTIQ+ people across Europe in light of the recent homophobic murder in SlovakiaOct 20, 2022
The rule of law in Malta, five years after the assassination of Daphne Caruana GaliziaMaltaOct 20, 2022
Amending budget 4/2022: update of revenue (own resources) and other technical adjustmentsOct 19, 2022
Commission Implementing Regulation (EU) 2022/1480 of 7 September 2022 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bensulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, esfenvalerate, etofenprox, fenoxaprop-P, fenpropidin, fenpyrazamine, fludioxonil, flufenacet, flumetralin, fosthiazate, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, prohexadione, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulphur, tebufenpyrad, tetraconazole, tri-allate, triflusulfuron and tritosulfuronOct 18, 2022